BPRO yields 9.01% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 6
Combined, BPRO + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BPRO + MRK for your $10,000?
BPRO seeks capital appreciation by investing in assets resilient to currency debasement, or the decline in major currencies value or purchasing power. Debasement-resistant assets (considered difficult to inflate or manipulate) include gold and other precious metals, as well as digital assets such as Bitcoin. The Fund invests in ETPs holding these assets and in ETFs with exposure to precious metal miners. Investments may include equity or debt securities issued by relevant companies, as well as sovereign debt, global currencies, and structured products or geared ETPs linked to these asset classes. Investments are not fixed, and selection utilizes macroeconomic views and proprietary modeling, which is reviewed at least weekly. The actively managed fund is expected to have significant gold exposure and does not invest directly in cryptocurrency. BPRO may use options contracts, taking different positions based on expected price movements of the underlying assets.
Full BPRO Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.